Longitudinal Oral Microbiome Sampling for BE
Start Date
3/19/2021
Completion Date
8/1/2027
Summary
This is a longitudinal cohort study to assess the impact of repeated sampling of an oral microbiome signature for Barrett's esophagus (BE). Potential participants will be identified through chart review of patients who have had an endoscopy in the past three years.
Detailed Description
Saliva collection is non-invasive and can be performed in clinical and non-clinical settings. As such, saliva testing is a highly attractive method for diagnosing and/or monitoring disease. The investigators previously showed that the bacterial make-up ("microbiome") of saliva is highly distinct in patients with and without Barrett's esophagus (BE), a precursor to esophageal cancer that normally can only be diagnosed by undergoing an upper endoscopy. While the microbiome of saliva is felt to be relatively stable over time, it is unclear whether a microbiome signature for Barrett's esophagus is reproducible within individuals. Also, repeated testing of saliva may improve the ability to diagnose Barrett's esophagus.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Sample collection
Conditions
Locations
University of Michigan
Ann Arbor, Michigan 48109
United States
Columbia University Irving Medical Center
New York, New York 10032
United States